[1]
Nelson, W.J.; Nusse, R. Convergence of Wnt, beta-catenin, and cadherin pathways. Science, 2004, 303, 1483-1487.
[2]
de Lau, W.; Peng, W.C.; Gros, P.; Clevers, H. The R-spondin/Lgr5/Rnf43 module: Regulator of Wnt signal strength. Genes Dev., 2014, 28, 305-316.
[3]
Reya, T.; Duncan, A.W.; Ailles, L.; Domen, J.; Scherer, D.C.; Willert, K.; Hintz, L.; Nusse, R.; Weissman, I.L. A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature, 2003, 423, 409-414.
[4]
Chenn, A.; Walsh, C.A. Regulation of cerebral cortical size by control of cell cycle exit in neural precursors. Science, 2002, 297, 365-369.
[5]
Hirabayashi, Y.; Itoh, Y.; Tabata, H.; Nakajima, K.; Akiyama, T.; Masuyama, N.; Gotoh, Y. The Wnt/beta-catenin pathway directs neuronal differentiation of cortical neural precursor cells. Development, 2004, 131, 2791-2801.
[6]
Veeman, M.T.; Axelrod, J.D.; Moon, R.T. A second canon. Functions and mechanisms of beta-catenin-independent Wnt signaling. Dev. Cell, 2003, 5, 367-377.
[7]
Keller, R. Shaping the vertebrate body plan by polarized embryonic cell movements. Science, 2002, 298, 1950-1954.
[8]
Mlodzik, M. Planar cell polarization: do the same mechanisms regulate Drosophila tissue polarity and vertebrate gastrulation? Trends Genet., 2002, 18, 564-571.
[9]
Torres, M.A.; Yang-Snyder, J.A.; Purcell, S.M.; DeMarais, A.A.; McGrew, L.L.; Moon, R.T. Activities of the Wnt-1 class of secreted signaling factors are antagonized by the Wnt-5A class and by a dominant negative cadherin in early Xenopus development. J. Cell Biol., 1996, 133, 1123-1137.
[10]
Ishitani, T.; Ninomiya-Tsuji, J.; Nagai, S.; Nishita, M.; Meneghini, M.; Barker, N.; Waterman, M.; Bowerman, B.; Clevers, H.; Shibuya, H.; Matsumoto, K. The TAK1-NLK-MAPK-related pathway antagonizes signalling between beta-catenin and transcription factor TCF. Nature, 1999, 399, 798-802.
[11]
Ishitani, T.; Kishida, S.; Hyodo-Miura, J.; Ueno, N.; Yasuda, J.; Waterman, M.; Shibuya, H.; Moon, R.T.; Ninomiya-Tsuji, J.; Matsumoto, K. The TAK1-NLK mitogen-activated protein kinase cascade functions in the Wnt-5a/Ca(2+) pathway to antagonize Wnt/beta-catenin signaling. Mol. Cell. Biol., 2003, 23, 131-139.
[12]
Park, M.; Moon, R.T. The planar cell-polarity gene stbm regulates cell behaviour and cell fate in vertebrate embryos. Nat. Cell Biol., 2002, 4, 20-25.
[13]
Topol, L.; Jiang, X.; Choi, H.; Garrett-Beal, L.; Carolan, P.J.; Yang, Y. Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3-independent beta-catenin degradation. J. Cell Biol., 2003, 162, 899-908.
[14]
Westfall, T.A.; Brimeyer, R.; Twedt, J.; Gladon, J.; Olberding, A.; Furutani-Seiki, M.; Slusarski, D.C. Wnt-5/pipetail functions in vertebrate axis formation as a negative regulator of Wnt/beta-catenin activity. J. Cell Biol., 2003, 162, 889-898.
[15]
Emami, K.H.; Nguyen, C.; Ma, H.; Kim, D.H.; Jeong, K.W.; Eguchi, M.; Moon, R.T.; Teo, J.L.; Oh, S.W.; Kim, H.Y.; Moon, S.H.; Ha, J.R.; Kahn, M. A small molecule inhibitor of beta-catenin/CREB-binding protein transcription [corrected] Proc. Natl. Acad. Sci. USA, 2004, 101, 12682-12687.
[16]
Ma, H.; Nguyen, C.; Lee, K.S.; Kahn, M. Differential roles for the coactivators CBP and p300 on TCF/beta-catenin-mediated survivin gene expression. Oncogene, 2005, 24, 3619-3631.
[17]
Teo, J.L.; Ma, H.; Nguyen, C.; Lam, C.; Kahn, M. Specific inhibition of CBP/beta-catenin interaction rescues defects in neuronal differentiation caused by a presenilin-1 mutation. Proc. Natl. Acad. Sci. USA, 2005, 102, 12171-12176.
[18]
McMillan, M.; Kahn, M. Investigating Wnt signaling: a chemogenomic safari. Drug Discov. Today, 2005, 10, 1467-1474.
[19]
Miyabayashi, T.; Teo, J.L.; Yamamoto, M.; McMillan, M.; Nguyen, C.; Kahn, M. Wnt/beta-catenin/CBP signaling maintains long-term murine embryonic stem cell pluripotency. Proc. Natl. Acad. Sci. USA, 2007, 104, 5668-5673.
[20]
Higuchi, Y.; Nguyen, C.; Yasuda, S.Y.; McMillan, M.; Hasegawa, K.; Kahn, M. Specific Direct Small Molecule p300/β-Catenin Antagonists Maintain Stem Cell Potency. Curr. Mol. Pharmacol., 2016, 9, 272-279.
[21]
Thomas, P.D.; Kahn, M. Kat3 coactivators in somatic stem cells and cancer stem cells: biological roles, evolution, and pharmacologic manipulation. Cell Biol. Toxicol., 2016, 32, 61-81.
[22]
Rieger, M.E.; Zhou, B.; Solomon, N.; Sunohara, M.; Li, C.; Nguyen, C.; Liu, Y.; Pan, J.H.; Minoo, P.; Crandall, E.D.; Brody, S.L.; Kahn, M.; Borok, Z. p300/β-Catenin Interactions Regulate Adult Progenitor Cell Differentiation Downstream of WNT5a/Protein Kinase C (PKC). J. Biol. Chem., 2016, 291, 6569-6582.
[23]
Eguchi, M.; Nguyen, C.; Lee, S.C.; Kahn, M. ICG-001, a novel small molecule regulator of TCF/beta-catenin transcription. Med. Chem., 2005, 1, 467-472.
[24]
Miyabayashi, T.; Yamamoto, M. Cell differentiation inhibiting
agent, cell culture method using the same, culture medium, and cultured
cell line. U.S. Patent 10, 875, 194, July 25, 2005.
[25]
Spencer, V.A.; Sun, J.M.; Li, L.; Davie, J.R. Chromatin immunoprecipitation: a tool for studying histone acetylation and transcription factor binding. Methods, 2003, 31, 67-75.
[26]
Eckner, R.; Ludlow, J.W.; Lill, N.L.; Oldread, E.; Arany, Z.; Modjtahedi, N.; DeCaprio, J.A.; Livingston, D.M.; Morgan, J.A. Association of p300 and CBP with simian virus 40 large T antigen. Mol. Cell. Biol., 1996, 16, 3454-3464.
[27]
Weiner, M.P.; Costa, G.L.; Schoettlin, W.; Cline, J.; Mathur, E.; Bauer, J.C. Site-directed mutagenesis of double-stranded DNA by the polymerase chain reaction. Gene, 1994, 151, 119-123.
[28]
Johnson, J.E.; Edwards, A.S.; Newton, A.C. A putative phosphatidylserine binding motif is not involved in the lipid regulation of protein kinase C. J. Biol. Chem., 1997, 272, 30787-30792.
[29]
Basch, M.L.; Ohyama, T.; Segil, N.; Groves, A.K. Canonical Notch signaling is not necessary for prosensory induction in the mouse cochlea: insights from a conditional mutant of RBPjkappa. J. Neurosci., 2011, 31, 8046-8058.
[30]
Shtutman, M.; Zhurinsky, J.; Simcha, I.; Albanese, C.; D’Amico, M.; Pestell, R.; Ben-Ze’ev, A. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc. Natl. Acad. Sci. USA, 1999, 96, 5522-5527.
[31]
Tetsu, O.; McCormick, F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature, 1999, 398, 422-426.
[32]
Yan, D.; Wiesmann, M.; Rohan, M.; Chan, V.; Jefferson, A.B.; Guo, L.; Sakamoto, D.; Caothien, R.H.; Fuller, J.H.; Reinhard, C.; Garcia, P.D.; Randazzo, F.M.; Escobedo, J.; Fantl, W.J.; Williams, L.T. Elevated expression of axin2 and hnkd mRNA provides evidence that Wnt/beta -catenin signaling is activated in human colon tumors. Proc. Natl. Acad. Sci. USA, 2001, 98, 14973-14978.
[33]
He, T.C.; Sparks, A.B.; Rago, C.; Hermeking, H.; Zawel, L.; da Costa, L.T.; Morin, P.J.; Vogelstein, B.; Kinzler, K.W. Identification of c-MYC as a target of the APC pathway. Science, 1998, 281, 1509-1512.
[34]
Mann, B.; Gelos, M.; Siedow, A.; Hanski, M.L.; Gratchev, A.; Ilyas, M.; Bodmer, W.F.; Moyer, M.P.; Riecken, E.O.; Buhr, H.J.; Hanski, C. Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas. Proc. Natl. Acad. Sci. USA, 1999, 96, 1603-1608.
[35]
Kumar, S.R.; Scehnet, J.S.; Ley, E.J.; Singh, J.; Krasnoperov, V.; Liu, R.; Manchanda, P.K.; Ladner, R.D.; Hawes, D.; Weaver, F.A.; Beart, R.W.; Singh, G.; Nguyen, C.; Kahn, M.; Gill, P.S. Preferential induction of EphB4 over EphB2 and its implication in colorectal cancer progression. Cancer Res., 2009, 69, 3736-3745.
[36]
Wilson, A.; Murphy, M.J.; Oskarsson, T.; Kaloulis, K.; Bettess, M.D.; Oser, G.M.; Pasche, A.C.; Knabenhans, C.; Macdonald, H.R.; Trumpp, A. c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation. Genes Dev., 2004, 18, 2747-2763.
[37]
Quinn, L.M.; Secombe, J.; Hime, G.R. Myc in stem cell behaviour: Insights from Drosophila. Adv. Exp. Med. Biol., 2013, 786, 269-285.
[38]
Rebel, V.I.; Kung, A.L.; Tanner, E.A.; Yang, H.; Bronson, R.T.; Livingston, D.M. Distinct roles for CREB-binding protein and p300 in hematopoietic stem cell self-renewal. Proc. Natl. Acad. Sci. USA, 2002, 99, 14789-14794.
[39]
Holmen, S.L.; Salic, A.; Zylstra, C.R.; Kirschner, M.W.; Williams, B.O. A novel set of Wnt-Frizzled fusion proteins identifies receptor components that activate beta -catenin-dependent signaling. J. Biol. Chem., 2002, 277, 34727-34735.
[40]
Kühl, M.; Sheldahl, L.C.; Malbon, C.C.; Moon, R.T. Ca(2+)/calmodulin-dependent protein kinase II is stimulated by Wnt and Frizzled homologs and promotes ventral cell fates in Xenopus. J. Biol. Chem., 2000, 275, 12701-12711.
[41]
Sheldahl, L.C.; Park, M.; Malbon, C.C.; Moon, R.T. Protein kinase C is differentially stimulated by Wnt and Frizzled homologs in a G-protein-dependent manner. Curr. Biol., 1999, 9, 695-698.
[42]
Weeraratna, A.T.; Jiang, Y.; Hostetter, G.; Rosenblatt, K.; Duray, P.; Bittner, M.; Trent, J.M. Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma. Cancer Cell, 2002, 1, 279-288.
[43]
Yuan, L.W.; Gambee, J.E. Phosphorylation of p300 at serine 89 by protein kinase C. J. Biol. Chem., 2000, 275, 40946-40951.
[44]
Szallasi, Z.; Smith, C.B.; Pettit, G.R.; Blumberg, P.M. Differential regulation of protein kinase C isozymes by bryostatin 1 and phorbol 12-myristate 13-acetate in NIH 3T3 fibroblasts. J. Biol. Chem., 1994, 269, 2118-2124.
[45]
Davies, S.P.; Reddy, H.; Caivano, M.; Cohen, P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J., 2000, 351, 95-105.
[46]
Gupta, K.P.; Ward, N.E.; Gravitt, K.R.; Bergman, P.J.; O’Brian, C.A. Partial reversal of multidrug resistance in human breast cancer cells by an N-myristoylated protein kinase C-alpha pseudosubstrate peptide. J. Biol. Chem., 1996, 271, 2102-2111.
[47]
Corcoran, E.E.; Joseph, J.D.; MacDonald, J.A.; Kane, C.D.; Haystead, T.A.; Means, A.R. Proteomic analysis of calcium/calmodulin-dependent protein kinase I and IV in vitro substrates reveals distinct catalytic preferences. J. Biol. Chem., 2003, 278, 10516-10522.
[48]
Yang, W.; Hong, Y.H.; Shen, X.Q.; Frankowski, C.; Camp, H.S.; Leff, T. Regulation of transcription by AMP-activated protein kinase: phosphorylation of p300 blocks its interaction with nuclear receptors. J. Biol. Chem., 2001, 276, 38341-38344.
[49]
Liu, Y.; Dentin, R.; Chen, D.; Hedrick, S.; Ravnskjaer, K.; Schenk, S.; Milne, J.; Meyers, D.J.; Cole, P.; Yates, J.; Olefsky, J.; Guarente, L.; Montminy, M. A fasting inducible switch modulates gluconeogenesis via activator/coactivator exchange. Nature, 2008, 456, 269-273.
[50]
Gusterson, R.J.; Yuan, L.W.; Latchman, D.S. Distinct serine residues in CBP and p300 are necessary for their activation by phenylephrine. Int. J. Biochem. Cell Biol., 2004, 36, 893-899.
[51]
Yuan, L.W.; Soh, J.W.; Weinstein, I.B. Inhibition of histone acetyltransferase function of p300 by PKCdelta. Biochim. Biophys. Acta, 2002, 1592, 205-211.
[52]
Bittner, M.; Meltzer, P.; Chen, Y.; Jiang, Y.; Seftor, E.; Hendrix, M.; Radmacher, M.; Simon, R.; Yakhini, Z.; Ben-Dor, A.; Sampas, N.; Dougherty, E.; Wang, E.; Marincola, F.; Gooden, C.; Lueders, J.; Glatfelter, A.; Pollock, P.; Carpten, J.; Gillanders, E.; Leja, D.; Dietrich, K.; Beaudry, C.; Berens, M.; Alberts, D.; Sondak, V. Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature, 2000, 406, 536-540.
[53]
Yan, D.; Wallingford, J.B.; Sun, T.Q.; Nelson, A.M.; Sakanaka, C.; Reinhard, C.; Harland, R.M.; Fantl, W.J.; Williams, L.T. Cell autonomous regulation of multiple Dishevelled-dependent pathways by mammalian Nkd. Proc. Natl. Acad. Sci. USA, 2001, 98, 3802-3807.
[54]
Dabdoub, A.; Kelley, M.W. Planar cell polarity and a potential role for a Wnt morphogen gradient in stereociliary bundle orientation in the mammalian inner ear. J. Neurobiol., 2005, 64, 446-457.
[55]
Fujita, H.; Orita, Y. An inner ear anomaly in golden hamsters. Am. J. Otolaryngol., 1988, 9, 224-231.
[56]
Comis, S.D.; Pickles, J.O.; Osborne, M.P.; Pepper, C.B. Tip-link organization in anomalously-oriented hair cells of the guinea pig cochlea. Hear. Res., 1989, 40, 205-211.
[57]
Fujita, H. Mutant golden hamsters with an abnormal outer hair cell stereociliary arrangement. Hear. Res., 1990, 44, 63-69.
[58]
Furness, D.N.; Hackney, C.M.; Hynd, A.N. Rotated stereociliary bundles and their relationship with the tectorial membrane in the guinea pig cochlea. Acta Otolaryngol., 1990, 109, 66-75.
[59]
Yoshida, N.; Liberman, M.C. Stereociliary anomaly in the guinea pig: effects of hair bundle rotation on cochlear sensitivity. Hear. Res., 1999, 131, 29-38.
[60]
Qian, D.; Jones, C.; Rzadzinska, A.; Mark, S.; Zhang, X.; Steel, K.P.; Dai, X.; Chen, P. Wnt5a functions in planar cell polarity regulation in mice. Dev. Biol., 2007, 306, 121-133.
[61]
Sasaki, T.; Hwang, H.; Nguyen, C.; Kloner, R.A.; Kahn, M. The small molecule Wnt signaling modulator ICG-001 improves contractile function in chronically infarcted rat myocardium. PLoS One, 2013, 8 e75010
[62]
Sasaki, T.; Kahn, M. Inhibition of β-catenin/p300 interaction proximalizes mouse embryonic lung epithelium. Transl. Respir. Med., 2014, 2, 8.
[63]
Huelsken, J.; Behrens, J. The Wnt signalling pathway. J. Cell Sci., 2002, 115, 3977-3978.
[64]
Steinhart, Z.; Angers, S. Wnt signaling in development and tissue homeostasis. Development, 2018, 145(11) pii: dev146589.
[65]
May-Simera, H.L.; Kelley, M.W. Cilia, Wnt signaling, and the cytoskeleton. Cilia, 2012, 1, 7.
[66]
Teo, J.L.; Kahn, M. The Wnt signaling pathway in cellular proliferation and differentiation: A tale of two coactivators. Adv. Drug Deliv. Rev., 2010, 62, 1149-1155.
[67]
Cavodeassi, F.; Carreira-Barbosa, F.; Young, R.M.; Concha, M.L.; Allende, M.L.; Houart, C.; Tada, M.; Wilson, S.W. Early stages of zebrafish eye formation require the coordinated activity of Wnt11, Fz5, and the Wnt/beta-catenin pathway. Neuron, 2005, 47, 43-56.
[68]
Winter, C.G.; Wang, B.; Ballew, A.; Royou, A.; Karess, R.; Axelrod, J.D.; Luo, L. Drosophila Rho-associated kinase (Drok) links Frizzled-mediated planar cell polarity signaling to the actin cytoskeleton. Cell, 2001, 105, 81-91.
[69]
Habas, R.; Kato, Y.; He, X. Wnt/Frizzled activation of Rho regulates vertebrate gastrulation and requires a novel Formin homology protein Daam1. Cell, 2001, 107, 843-854.
[70]
Habas, R.; Dawid, I.B.; He, X. Coactivation of Rac and Rho by Wnt/Frizzled signaling is required for vertebrate gastrulation. Genes Dev., 2003, 17, 295-309.
[71]
Penzo-Mendèz, A.; Umbhauer, M.; Djiane, A.; Boucaut, J.C.; Riou, J.F. Activation of Gbetagamma signaling downstream of Wnt-11/Xfz7 regulates Cdc42 activity during Xenopus gastrulation. Dev. Biol., 2003, 257, 302-314.
[72]
Manegold, P.; Lai, K.K.Y.; Wu, Y.; Teo, J.L.; Lenz, H.J.; Genyk, Y.S.; Pandol, S.J.; Wu, K.; Lin, D.P.; Chen, Y.; Nguyen, C.; Zhao, Y.; Kahn, M. Differentiation Therapy Targeting the β-Catenin/CBP
Interaction in Pancreatic Cancer. Cancers (Basel), 2018, 10(4), pii. E95.
[73]
Yamanaka, H.; Moriguchi, T.; Masuyama, N.; Kusakabe, M.; Hanafusa, H.; Takada, R.; Takada, S.; Nishida, E. JNK functions in the non-canonical Wnt pathway to regulate convergent extension movements in vertebrates. EMBO Rep., 2002, 3, 69-75.
[74]
Kühl, M.; Sheldahl, L.C.; Park, M.; Miller, J.R.; Moon, R.T. The Wnt/Ca2+ pathway: a new vertebrate Wnt signaling pathway takes shape. Trends Genet., 2000, 16, 279-283.
[75]
Sato, N.; Meijer, L.; Skaltsounis, L.; Greengard, P.; Brivanlou, A.H. Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat. Med., 2004, 10, 55-63.
[76]
Boland, G.M.; Perkins, G.; Hall, D.J.; Tuan, R.S. Wnt 3a promotes proliferation and suppresses osteogenic differentiation of adult human mesenchymal stem cells. J. Cell. Biochem., 2004, 93, 1210-1230.
[77]
Mohammed, M.K.; Shao, C.; Wang, J.; Wei, Q.; Wang, X.; Collier, Z.; Tang, S.; Liu, H.; Zhang, F.; Huang, J.; Guo, D.; Lu, M.; Liu, F.; Liu, J.; Ma, C.; Shi, L.L.; Athiviraham, A.; He, T.C.; Lee, M.J. Wnt/β-catenin signaling plays an ever-expanding role in stem cell self-renewal, tumorigenesis and cancer chemoresistance. Genes Dis., 2016, 3, 11-40.
[78]
Koyanagi, M.; Haendeler, J.; Badorff, C.; Brandes, R.P.; Hoffmann, J.; Pandur, P.; Zeiher, A.M.; Kühl, M.; Dimmeler, S. Non-canonical Wnt signaling enhances differentiation of human circulating progenitor cells to cardiomyogenic cells. J. Biol. Chem., 2005, 280, 16838-16842.
[79]
Schulte, G.; Bryja, V.; Rawal, N.; Castelo-Branco, G.; Sousa, K.M.; Arenas, E. Purified Wnt-5a increases differentiation of midbrain dopaminergic cells and dishevelled phosphorylation. J. Neurochem., 2005, 92, 1550-1553.
[80]
Xiao, Q.; Chen, Z.; Jin, X.; Mao, R. The many postures of noncanonical Wnt signaling in development and diseases. Biomed. Pharmacother., 2017, 93, 359-369.
[81]
Wallingford, J.B.; Fraser, S.E.; Harland, R.M. Convergent extension: the molecular control of polarized cell movement during embryonic development. Dev. Cell, 2002, 2, 695-706.
[82]
Zhao, Y.; Masiello, D.; McMillian, M.; Nguyen, C.; Wu, Y.; Melendez, E.; Smbatyan, G.; Kida, A.; He, Y.; Teo, J.L.; Kahn, M. CBP/catenin antagonist safely eliminates drug-resistant leukemia-initiating cells. Oncogene, 2016, 35, 3705-3717.
[83]
Kim, Y.M.; Gang, E.J.; Kahn, M. CBP/Catenin antagonists: Targeting LSCs’ Achilles heel. Exp. Hematol., 2017, 52, 1-11.
[84]
Graves, J.D. Krebs, E.G. Protein phosphorylation and signal transduction. Pharmacol. Ther., 1999, 82, 111-121.
Download PDF Flyer